Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Eva-Maria and Eckhard Mandelkow have been awarded the Potamkin Prize

15.04.2011
Targets for Alzheimer therapy

Drs Eva-Maria and Eckhard Mandelkow, researchers at the Max Planck Unit for Structural Molecular Biology at DESY (Hamburg) and at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, have been honored with the Potamkin Prize from the American Academy of Neurology (AAN) for their contributions to the field of dementia research.

The award ceremony takes place on 14 April at the Annual Meeting of the AAN in Honolulu (Hawaii). Eva-Maria and Eckhard Mandelkow share the prize, endowed with 100 000 U.S. dollars, with Dennis Dickson (Mayo Clinic, Jacksonville, Florida). The Potamkin Prize is one of the most prestigious awards in the field of dementia research. Since 1988, this important scientific honor is donated by the Potamkin entrepreneurial family from New York.

Together with their team, Eva-Maria and Eckhard Mandelkow have achieved major breakthroughs in Alzheimer research through their work on a protein termed tau. In the normal state tau strengthens the cytoskeleton in neurons and is involved in the transport of cell organelles. But very early in Alzheimer's disease it changes, becomes detached from the cytoskeleton and lumps together as cellular debris.

In their seminal work Eva-Maria and Eckhard Mandelkow investigated the mechanism of pathological tau aggregation and showed which parts of the protein are crucial for this process. Insights from this research then allowed them to investigate the consequences of tau protein aggregation in nerve cells in more detail using mouse and cellular models. The result showed that only forms of tau that are capable of aggregation destroy the synapses of nerve cells. If these forms of tau accumulate in neurons the mice perform poorly in learning and memory tests, thus showing typical symptoms of Alzheimer's disease. If the production of toxic tau in the cells of the mice is halted, synapses regenerate and the mice recover from their memory disorder. This crucial observation shows that the disease process is in principle reversible. With this work Eva-Maria and Eckhard Mandelkow provide an important starting point for the development of potential therapies. Their investigations on tau structure and their mouse experiments now allow the identification of drugs that counteract the toxic properties of tau and - at least in mice - can combat cognitive impairment.

Dr. Eckhard Mandelkow studied physics and earned his doctorate at the Max Planck Institute for Medical Research in Heidelberg on the structure of virus proteins. In his postdoctoral training at Brandeis University (Massachusetts, USA) he looked into proteins of the cytoskeleton and then continued this line of research with a focus on the structure and function of neuronal proteins, especially of motor proteins and tau proteins and their pathological changes during neurodegeneration. He is head of a laboratory of the Max Planck Society at the German Electron Synchrotron DESY and is currently building a new research group at the DZNE site in Bonn.

Dr. Eva-Maria Mandelkow studied medicine and worked for several years as physician in the clinic and then shifted her focus to basic research. She earned her doctorate at the Max Planck Institute for Medical Research in Heidelberg on a topic in muscle physiology. In subsequent research stays at Brandeis University (Massachusetts, USA), Scripps Research Institute (La Jolla, California) and at the MRC Laboratory in Cambridge (United Kingdom) she worked on proteins of the cytoskeleton. Eva-Maria Mandelkow heads a research group at the Max Planck lab in Hamburg, which deals with cell and mouse models of Alzheimer's disease. She also moves to the DZNE in Bonn as a group leader in 2011.

Contact information:
Drs. Eva-Maria und Eckhard Mandelkow
Max Planck Research Unit for Structural Molecular Biology
c/o DESY, Notkestrasse 85, 22607 Hamburg
German Center for Neurodegenerative Diseases (DZNE)
Ludwig-Erhard-Allee 2, 53175 Bonn
Tel: +49 (0)40-89982801, +49 (0)228-43302-263
Email: office@mpasmb.desy.de, mandelkow@dzne.de
Dr. Katrin Weigmann
German Center for Neurodegenerative Diseases (DZNE)
Press- and Public Relations
Tel: +49 (0) 228 43302 /263
Mobil: +49 (0) 173 – 5471350
Email: katrin.weigmann@dzne.de

Katrin Weigmann | idw
Further information:
http://www.dzne.de
http://www.mpasmb-hamburg.mpg.de
http://www.aan.com/science/awards/?fuseaction=home.info&id=13

More articles from Awards Funding:

nachricht Helmholtz International Fellow Award for Sarah Amalia Teichmann
20.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Scientist from Kiel University coordinates Million Euros Project in Inflammation Research
19.01.2017 | Christian-Albrechts-Universität zu Kiel

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>